Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Metastatic Malignancies”

391 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 391 results

Testing effectiveness (Phase 2)Study completedNCT01034631
What this trial is testing

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Hoosier Cancer Research Network 154
Testing effectiveness (Phase 2)Ended earlyNCT00670046
What this trial is testing

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Early research (Phase 1)Study completedNCT00496860
What this trial is testing

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

Who this might be right for
Progressive Metastatic Malignancies
Altor BioScience 26
Large-scale testing (Phase 3)Active Not RecruitingNCT04674683
What this trial is testing

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

Who this might be right for
Unresectable or Metastatic MelanomaProgressive Brain Metastasis
HUYABIO International, LLC. 450
Early research (Phase 1)Looking for participantsNCT06439836
What this trial is testing

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

Who this might be right for
Metastatic Urothelial CarcinomaUnresectable Urothelial Carcinoma
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT01841736
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Who this might be right for
Foregut Neuroendocrine TumorHindgut Neuroendocrine TumorMetastatic Digestive System Neuroendocrine Tumor G1+5 more
National Cancer Institute (NCI) 171
Testing effectiveness (Phase 2)UnknownNCT02296203
What this trial is testing

Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT01688492
What this trial is testing

Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT05599789
What this trial is testing

Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Peking Union Medical College Hospital 47
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Testing effectiveness (Phase 2)Looking for participantsNCT04989725
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

Who this might be right for
Head and Neck CancerMetastatic CancerOligoprogressive
Centre hospitalier de l'Université de Montréal (CHUM) 46
Early research (Phase 1)Study completedNCT01862900
What this trial is testing

Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions

Who this might be right for
Metastatic Breast CancerLung MetastasesLiver Metastases
Providence Health & Services 14
Not applicableApproved For MarketingNCT01606982
What this trial is testing

Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT03531827
What this trial is testing

Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Who this might be right for
Metastatic Castration Resistant Prostate CancerProstate Neoplasms
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Testing effectiveness (Phase 2)Study completedNCT00106613
What this trial is testing

A Research Study for Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellNeoplasm Metastasis
Celgene 30
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Early research (Phase 1)Study completedNCT00458731
What this trial is testing

Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+59 more
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Ended earlyNCT01828476
What this trial is testing

Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 13
Testing effectiveness (Phase 2)Study completedNCT00317720
What this trial is testing

Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
M.D. Anderson Cancer Center 40
Load More Results